The Phenomenon of the Cross-Resistance of Breast Cancer to Target and Hormonal Drugs: The Role of Epigenetic Reconstruction-Reference-Cited by-同舟云学术

The Phenomenon of the Cross-Resistance of Breast Cancer to Target and Hormonal Drugs: The Role of Epigenetic Reconstruction

Published:2023-03-16 Issue: Volume: Page:
ISSN:
Container-title:IECC 2023
language:
Short-container-title:

Author:

Andreeva Olga E.¹^ORCID,Shchegolev Yuri Y.¹,Scherbakov Alexander M.¹^ORCID,Sorokin Danila V.¹,Vinokurova Svetlana V.¹^ORCID,Katargin Alexey N.¹,Salnikova Diana I.¹,Krasil’nikov Mikhail A.¹

Affiliation:

1. Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow 115522, Russia

Publisher

MDPI

Link

https://www.mdpi.com/2673-9992/20/1/5/pdf

Reference14 articles.

1. Endocrine resistance in breast cancer—An overview and update;Clarke;Mol. Cell. Endocrinol.,2015

2. Mechanism of resistance to endocrine therapy in breast cancer: The important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer;Araki;Breast Cancer,2017

3. Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro;Citi;Cancer Chemother. Pharm.,2018

4. Ovarian cancer: Epigenetics, drug resistance, and progression;Xie;Cancer Cell Int.,2021

5. Molecular epigenetic dynamics in breast carcinogenesis;Hazra;Arch. Pharm. Res.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells;Advances in Molecular Oncology;2023-12-14